Cost-effectiveness study of a lipid-lowering therapy in hyperlipoproteinaemia type IIb and type IV (Frederickson).
Bergemann R, Brandt A, Siegrist W.
Pharmacoeconomics. 1993 Feb;3(2):131-9. doi: 10.2165/00019053-199303020-00006.
Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with Frederickson type IV dyslipidemia phenotype.
Bermúdez-Pirela V, Souki A, Cano-Ponce C, Bermúdez-Arias F, Mengual-Moreno E, Leal-Gonzalez E, Lemus-Antepaz M, de Bravo MC, de Díaz AA, de Pirela NL, Cano-Peñaloza R, Puche-Medina G, Arraiz N, Reyna-Villazmil N, Contreras F, Israili ZH, Valasco M.
Am J Ther. 2007 Mar-Apr;14(2):213-20. doi: 10.1097/01.pap.0000249920.70815.2d.
[Essential hypercholesteremic xanthomatosis (Frederickson's hyperlipoproteinemia type IIb)].
Schink W.
Handchirurgie. 1976;8(1):37.
[Influence of fat or carbohydrate rich diet on the serum lipoprotein pattern of a child with primary hypertriglyceridemia (type V hyperlipoproteinemia according to Frederickson) (author's transl)].
Müller WD, Kostner GM.
Wien Klin Wochenschr. 1974 Dec 27;86(24):757-62.
[Case of type IV hyperlipoproteinemia (Frederickson's classification)].
Kwiatkowski S, Smolik R, Szechiński J.
Wiad Lek. 1972 Sep 1;25(17):1591-4.
Acute tendinitis and arthritis. A presenting symptom of familial type II hyperlipoproteinemia.
Glueck CJ, Levy RI, Frederickson DS.
JAMA. 1968 Dec 23;206(13):2895-7. doi: 10.1001/jama.206.13.2895.
Studies of triacyglycerol structure of very low density lipoproteins of normolipemic subjects and patients with type III and type IV hyperlipoproteinemia.
Myher JJ, Kuksis A, Breckenridge WC, Little JA.
Lipids. 1984 Sep;19(9):683-91. doi: 10.1007/BF02534528.
Primary hyperlipoproteinemia in xanthomatosis.
Hessel LW, Vermeer BJ, Polano MK, De Jonge H, De Pagter HA, Van Gent CM.
Clin Chim Acta. 1976 Jun 15;69(3):405-16. doi: 10.1016/0009-8981(76)90112-1.
Comparative studies of triacylglycerol structure of very low density lipoproteins and chylomicrons of normolipemic subjects and patients with type II hyperlipoproteinemia.
Myher JJ, Kuksis A, Breckenridge WC, McGuire V, Little JA.
Lipids. 1985 Feb;20(2):90-101. doi: 10.1007/BF02534214.
Familial hyperlipidemia in stroke in the young.
Bansal BC, Sood AK, Bansal CB.
Stroke. 1986 Nov-Dec;17(6):1142-5. doi: 10.1161/01.str.17.6.1142.
